GILD

166.4300.06%
EE

Erin E. Burkhart

Senior VP, Controller & Chief Accounting Officer

Ms. Erin E. Burkhart is Senior Vice President, Controller and Chief Accounting Officer of Gilead Sciences, Inc. from September 22, 2025. Ms. Burkhart was Group Vice President & Chief Accounting Officer of BioMarin Pharmaceutical Inc. from May 2022 to September 2, 2025. She has B.S. in Accounting from Butler University. Ms. Burkhart is a highly experienced accounting and finance executive with deep technical accounting skills, global corporate finance experience, biopharma business acumen and leadership capabilities. She has robust accounting experience across a number of specialized areas, large-scale business operating model experience and a successful track record of leading transformational business initiatives. In this role, Ms. Burkhart assumed principal accounting officer responsibilities, including setting BioMarin's global accounting vision and strategy, team leadership, global controllership and accounting operations and systems and maintaining accounting policies and financial internal controls. Ms. Burkhart was a key member of the management team leading the financial aspects of BioMarin's anticipated transformational growth. With years of accounting and finance experience, Ms. Burkhart held accounting roles of increasing responsibility at Eli Lilly & Co., which include leading accounting operations second to the Chief Accounting Officer, leading U.S. gross-to-net revenue reporting, technical accounting and corporate audit services. Previously, Ms. Burkhart was the Financial Reporting Director for Stonegate Mortgage Corp and the Technical Accounting Director at Anthem, Inc. and she started her career in public accounting with Arthur Andersen & Deloitte. Ms. Burkhart is a CPA and holds a BS in Accounting from Butler University.

Positions